The burgeoning field of diabetes care has witnessed the rise of GLP-3 receptor agonists, representing a significant class of therapeutics. Assessing these medications requires a close look at their respective profiles. https://junaidsprx633229.ka-blogs.com/91960497/glp-3-receptor-activators-a-relative-analysis